Get the Stockscreener App
3.3706
50.89%
1.1306
Avalon Globocare Corp stock is traded at $3.3706, with a volume of 32.49M.
It is up +50.89% in the last 24 hours and up +5.44% over the past month.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
See More
Previous Close:
$2.24
Open:
$4.11
24h Volume:
32.49M
Relative Volume:
38.05
Market Cap:
$3.71M
Revenue:
$1.23M
Net Income/Loss:
$-9.23M
P/E Ratio:
-2.3905
EPS:
-1.41
Net Cash Flow:
$-7.69M
1W Performance:
+2.74%
1M Performance:
+5.44%
6M Performance:
-8.62%
1Y Performance:
-66.37%
1-Day Range:
$3.2101
$4.69
1-Week Range:
$2.11
$4.69
52-Week Range:
$2.11
$21.60
Avalon Globocare Corp Stock (ALBT) Company Profile
Name
Avalon Globocare Corp
Sector
Industry
Phone
732-780-4400
Address
4400 ROUTE 9, FREEHOLD
Avalon Globocare Corp Stock (ALBT) Latest News
U.S. Stock market: Verrica Pharmaceuticals and Marqeta stocks plummet over 37%, while Avalon GloboCare soars 75% in volatile market trend - Business Upturn
Avalon Globocare stock hits 52-week low at $2.4 amid market challenges By Investing.com - Investing.com South Africa
Avalon Globocare stock hits 52-week low at $2.4 amid market challenges - Investing.com
Avalon GloboCare Appoints Dr. Charles Cavo to Scientific Advisory Board Support for KetoAir Sales - Defense World
Avalon GloboCare faces Nasdaq delisting after rule breach By Investing.com - Investing.com South Africa
Avalon GloboCare faces Nasdaq delisting after rule breach - Investing.com India
Avalon appoints Cavto to Scientific Advisory Board - TipRanks
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales - GlobeNewswire
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update - Defense World
Avalon GloboCare Announces Reverse Stock Split and Decrease in Shares By Investing.com - Investing.com South Africa
Avalon GloboCare Announces Reverse Stock Split and Decrease in Shares - Investing.com
Avalon Globocare stock hits 52-week high at $3.45 By Investing.com - Investing.com South Africa
Avalon Globocare stock hits 52-week high at $3.45 - Investing.com India
Avalon GloboCare Stock Set to Reverse Split on Monday, October 28th (NASDAQ:ALBT) - Defense World
Avalon GloboCare Collaborates for Cannabis Breathalyzer Development - TipRanks
Avalon GloboCare and Qi Diagnostics Enter into Memorandum - GlobeNewswire
Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving - StockTitan
EXCLUSIVE: Avalon GloboCare Inks MoU With Qi Diagnostics For Proposed Co-Development Of Real-Time Cannabis Breathalyzer - Yahoo Finance
Avalon GloboCare to enact reverse stock split By Investing.com - Investing.com Australia
Avalon GloboCare to enact reverse stock split - Investing.com
Avalon GloboCare Announces 1-for-15 Reverse Stock Split - citybiz
ALBTAvalon GloboCare Corp. Latest Stock News & Market Updates - StockTitan
Avalon GloboCare Announces Reverse Stock Split Strategy - TipRanks
Avalon GloboCare Announces 1-for-15 Reverse Stock Split as Part of Nasdaq Compliance Plan - GlobeNewswire
Avalon Globocare stock hits 52-week low at $0.19 - Investing.com
Avalon Globocare stock hits 52-week low at $0.19 By Investing.com - Investing.com UK
Avalon GloboCare announces key shareholder decisions - Investing.com India
Avalon GloboCare announces key shareholder decisions By Investing.com - Investing.com UK
Examining Avalon GloboCare Corp (ALBT) more closely is necessary - US Post News
Avalon GloboCare Corp (ALBT) Stock: A Year of Highs and Lows - The InvestChronicle
Avalon GloboCare Showcases KetoAir™ at Keto Conference - TipRanks
Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer Device - The Manila Times
Acumen Health Holdings to Acquire Avenova Brand Enhancing Eye Health Portfolio - MyChesCo
Avantis Emerging Markets Equity ETF (NYSEARCA:AVEM) is Libra Wealth LLC’s 7th Largest Position - Defense World
Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals - PR Newswire
Avalon Globocare stock hits 52-week low at $0.2 - Investing.com India
Avalon Globocare stock hits 52-week low at $0.2 By Investing.com - Investing.com Canada
Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I - ForexTV.com
ALBT’s Stock Market Adventure: -57.35% YTD Growth Amidst Volatility - The InvestChronicle
Gabon Seeks Cameroon’s Support for ASECNA Director Election - Business in Cameroon
Houses burning as population evacuated due to fire - The Portugal News
Defence stock jumps 7% after receiving an order worth ₹ 9.39 Cr from NewSpace India - Trade Brains
Wildfires in Portugal’s Aveiro district have claimed two lives - Famagusta Gazette
Avantis Group Partners with AMS to expand presence in Hong Kong's maritime market - 4C Offshore
Some hogs died after ASF-controlled vaccination in Batangas town - Daily Tribune (Philippines)
Raymond James downgrades AeroVironment after contract suspension - XM
Daily recap: Three firms bid for Avramar Greek assets; Canada lobster harvesters seek minister's resignation - Undercurrent News
Mayor calls for water rationing due to fire - The Portugal News
Two Dead As Wildfires Sweep Portugal's Aveiro District - MENAFN.COM
Job roles at Bournemouth insurance firm replaced in India - Bournemouth Echo
Avalon GloboCare Corp’s results are impressive - US Post News
Avalon Globocare Corp Stock (ALBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.45%
2.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):